Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

NIH grant to support advancement of heroin vaccine OPNT-005

Oct. 22, 2018

Eagle enters agreement with USAMRICD to evaluate neuroprotective effects of Ryanodex

Oct. 4, 2018

AAV-mediated gene transfer of scFvs shows viability for treatment of methamphetamine abuse in mice

Sep. 25, 2018

Gene therapy for cocaine addiction

Sep. 25, 2018

Treatment with the novel GPR88 agonist RTI-13951-33 reduces alcohol intake in vivo

Sep. 21, 2018

Amygdala Neurosciences announces SEARCH phase II studies with ANS-6637

Sep. 20, 2018

NIDA award supports Ensysce's development of opioid overdose protection platform

Sep. 19, 2018

NIAAA to conduct phase II study of ANS-6637 for alcohol use disorder

Sep. 13, 2018

Phoenix PharmaLabs receives support to study PPL-103 for cocaine addiction

Sep. 6, 2018

Lawrence Livermore National Laboratory develops nerve agent antidote LLNL-02

Aug. 27, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...